Title : A phase II multicenter clinical trial of systemic bexarotene in psoriasis.

Pub. Date : 2004 Aug

PMID : 15280844






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: Bexarotene, a novel and unique synthetic P, RXR-selective retinoid, is available as a treatment for cutaneous T-cell lymphoma. Retinoids retinoid X receptor alpha Homo sapiens